Table of Content

1 Human Herpersvirus 5 (HHV-5) Drug Market Overview
1.1 Human Herpersvirus 5 (HHV-5) Drug Product Scope
1.2 Human Herpersvirus 5 (HHV-5) Drug Segment by Type
1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Ganciclovir
1.2.3 Valerian Gilivir Drugs
1.2.4 Acyclovir Drugs
1.2.5 Valacyclovir Drugs
1.2.6 Foscarnet Sodium Drugs
1.3 Human Herpersvirus 5 (HHV-5) Drug Segment by Application
1.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunodeficiency Crowd
1.3.3 Organ Transplant Crowd
1.3.4 CMV Herpes Crowd
1.4 Human Herpersvirus 5 (HHV-5) Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Herpersvirus 5 (HHV-5) Drug Price Trends (2016-2027)

2 Human Herpersvirus 5 (HHV-5) Drug Estimates and Forecasts by Region
2.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Herpersvirus 5 (HHV-5) Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region (2016-2021)
2.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)
2.4.2 Europe Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)
2.4.3 China Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)
2.4.4 Japan Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)
2.4.6 India Human Herpersvirus 5 (HHV-5) Drug Estimates and Projections (2016-2027)

3 Global Human Herpersvirus 5 (HHV-5) Drug Competition Landscape by Players
3.1 Global Top Human Herpersvirus 5 (HHV-5) Drug Players by Sales (2016-2021)
3.2 Global Top Human Herpersvirus 5 (HHV-5) Drug Players by Revenue (2016-2021)
3.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Herpersvirus 5 (HHV-5) Drug as of 2020)
3.4 Global Human Herpersvirus 5 (HHV-5) Drug Average Price by Company (2016-2021)
3.5 Manufacturers Human Herpersvirus 5 (HHV-5) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
4.1 Global Human Herpersvirus 5 (HHV-5) Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2016-2021)
4.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Price Forecast by Type (2022-2027)

5 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
5.1 Global Human Herpersvirus 5 (HHV-5) Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2016-2021)
5.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Price Forecast by Application (2022-2027)

6 North America Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
6.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Company
6.1.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
6.1.2 North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
6.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
6.2.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
6.3 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
6.3.1 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2022-2027)

7 Europe Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
7.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Company
7.1.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
7.1.2 Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
7.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
7.2.1 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)

8 China Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
8.1 China Human Herpersvirus 5 (HHV-5) Drug Sales by Company
8.1.1 China Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
8.1.2 China Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
8.2 China Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
8.2.1 China Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
8.3 China Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
8.3.1 China 156 Sales Breakdown by Application (2016-2021)
8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
9.1 Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Company
9.1.1 Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
9.1.2 Japan Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
9.2 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
9.2.1 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
10.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Company
10.1.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
10.2.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures
11.1 India Human Herpersvirus 5 (HHV-5) Drug Sales by Company
11.1.1 India Human Herpersvirus 5 (HHV-5) Drug Sales by Company (2016-2021)
11.1.2 India Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021)
11.2 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type
11.2.1 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Type (2022-2027)
11.3 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application
11.3.1 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Human Herpersvirus 5 (HHV-5) Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Herpersvirus 5 (HHV-5) Drug Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.1.5 Roche Recent Development
12.2 Livzon Pharmaceuticals
12.2.1 Livzon Pharmaceuticals Corporation Information
12.2.2 Livzon Pharmaceuticals Business Overview
12.2.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.2.5 Livzon Pharmaceuticals Recent Development
12.3 Sichuan Cologne Pharmaceutical
12.3.1 Sichuan Cologne Pharmaceutical Corporation Information
12.3.2 Sichuan Cologne Pharmaceutical Business Overview
12.3.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.3.5 Sichuan Cologne Pharmaceutical Recent Development
12.4 Hubei Branch benefits medicine
12.4.1 Hubei Branch benefits medicine Corporation Information
12.4.2 Hubei Branch benefits medicine Business Overview
12.4.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.4.5 Hubei Branch benefits medicine Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Upright and clear
12.6.1 Upright and clear Corporation Information
12.6.2 Upright and clear Business Overview
12.6.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.6.5 Upright and clear Recent Development
12.7 Chongqing Winbond (acquisition of Sichuan Mingxin)
12.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Corporation Information
12.7.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Business Overview
12.7.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.7.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
12.8 Haikou Kellett
12.8.1 Haikou Kellett Corporation Information
12.8.2 Haikou Kellett Business Overview
12.8.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.8.5 Haikou Kellett Recent Development
12.9 On the drug new Asia
12.9.1 On the drug new Asia Corporation Information
12.9.2 On the drug new Asia Business Overview
12.9.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.9.5 On the drug new Asia Recent Development
12.10 Chongqing Fu'an Pharmaceutical
12.10.1 Chongqing Fu'an Pharmaceutical Corporation Information
12.10.2 Chongqing Fu'an Pharmaceutical Business Overview
12.10.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.10.5 Chongqing Fu'an Pharmaceutical Recent Development
12.11 Shandong Luo Xin Pharmaceutical
12.11.1 Shandong Luo Xin Pharmaceutical Corporation Information
12.11.2 Shandong Luo Xin Pharmaceutical Business Overview
12.11.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.11.5 Shandong Luo Xin Pharmaceutical Recent Development
12.12 Yangtze River Pharmaceutical
12.12.1 Yangtze River Pharmaceutical Corporation Information
12.12.2 Yangtze River Pharmaceutical Business Overview
12.12.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.12.5 Yangtze River Pharmaceutical Recent Development
12.13 Qianjiang Pharmaceuticals
12.13.1 Qianjiang Pharmaceuticals Corporation Information
12.13.2 Qianjiang Pharmaceuticals Business Overview
12.13.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.13.5 Qianjiang Pharmaceuticals Recent Development
12.14 Wuhan Hualong
12.14.1 Wuhan Hualong Corporation Information
12.14.2 Wuhan Hualong Business Overview
12.14.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Products Offered
12.14.5 Wuhan Hualong Recent Development

13 Human Herpersvirus 5 (HHV-5) Drug Manufacturing Cost Analysis
13.1 Human Herpersvirus 5 (HHV-5) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Herpersvirus 5 (HHV-5) Drug
13.4 Human Herpersvirus 5 (HHV-5) Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Herpersvirus 5 (HHV-5) Drug Distributors List
14.3 Human Herpersvirus 5 (HHV-5) Drug Customers

15 Market Dynamics
15.1 Human Herpersvirus 5 (HHV-5) Drug Market Trends
15.2 Human Herpersvirus 5 (HHV-5) Drug Drivers
15.3 Human Herpersvirus 5 (HHV-5) Drug Market Challenges
15.4 Human Herpersvirus 5 (HHV-5) Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Herpersvirus 5 (HHV-5) Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Herpersvirus 5 (HHV-5) Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Herpersvirus 5 (HHV-5) Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Region (2016-2021)
Table 6. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Region (2016-2021)
Table 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Company (2016-2021)
Table 14. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Company (2016-2021)
Table 16. Global Human Herpersvirus 5 (HHV-5) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Herpersvirus 5 (HHV-5) Drug as of 2020)
Table 17. Global Human Herpersvirus 5 (HHV-5) Drug Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Human Herpersvirus 5 (HHV-5) Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Human Herpersvirus 5 (HHV-5) Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2016-2021)
Table 23. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Herpersvirus 5 (HHV-5) Drug Price (US$/Unit) by Type (2016-2021)
Table 25. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Type (2022-2027)
Table 26. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2022-2027)
Table 28. Global Human Herpersvirus 5 (HHV-5) Drug Price (US$/Unit) by Type (2022-2027)
Table 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2016-2021)
Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Herpersvirus 5 (HHV-5) Drug Price (US$/Unit) by Application (2016-2021)
Table 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Application (2022-2027)
Table 35. Global Human Herpersvirus 5 (HHV-5) Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2022-2027)
Table 37. Global Human Herpersvirus 5 (HHV-5) Drug Price (US$/Unit) by Application (2022-2027)
Table 38. North America Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 40. North America Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 44. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 46. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 48. North America Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 62. China Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 63. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 64. China Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 66. China Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 68. China Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 70. China Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 72. China Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 98. India Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) by Company (2016-2021)
Table 99. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Company (2016-2021)
Table 100. India Human Herpersvirus 5 (HHV-5) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Company (2016-2021)
Table 102. India Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2016-2021)
Table 104. India Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type (2022-2027)
Table 106. India Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2016-2021)
Table 108. India Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Roche Human Herpersvirus 5 (HHV-5) Drug Product
Table 114. Roche Recent Development
Table 115. Livzon Pharmaceuticals Corporation Information
Table 116. Livzon Pharmaceuticals Description and Business Overview
Table 117. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product
Table 119. Livzon Pharmaceuticals Recent Development
Table 120. Sichuan Cologne Pharmaceutical Corporation Information
Table 121. Sichuan Cologne Pharmaceutical Description and Business Overview
Table 122. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product
Table 124. Sichuan Cologne Pharmaceutical Recent Development
Table 125. Hubei Branch benefits medicine Corporation Information
Table 126. Hubei Branch benefits medicine Description and Business Overview
Table 127. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Product
Table 129. Hubei Branch benefits medicine Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Upright and clear Corporation Information
Table 136. Upright and clear Description and Business Overview
Table 137. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Product
Table 139. Upright and clear Recent Development
Table 140. Chongqing Winbond (acquisition of Sichuan Mingxin) Corporation Information
Table 141. Chongqing Winbond (acquisition of Sichuan Mingxin) Description and Business Overview
Table 142. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Product
Table 144. Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
Table 145. Haikou Kellett Corporation Information
Table 146. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Haikou Kellett Description and Business Overview
Table 148. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Product
Table 149. Haikou Kellett Recent Development
Table 150. On the drug new Asia Corporation Information
Table 151. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. On the drug new Asia Description and Business Overview
Table 153. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Product
Table 154. On the drug new Asia Recent Development
Table 155. Chongqing Fu'an Pharmaceutical Corporation Information
Table 156. Chongqing Fu'an Pharmaceutical Description and Business Overview
Table 157. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product
Table 159. Chongqing Fu'an Pharmaceutical Recent Development
Table 160. Shandong Luo Xin Pharmaceutical Corporation Information
Table 161. Shandong Luo Xin Pharmaceutical Description and Business Overview
Table 162. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product
Table 164. Shandong Luo Xin Pharmaceutical Recent Development
Table 165. Yangtze River Pharmaceutical Corporation Information
Table 166. Yangtze River Pharmaceutical Description and Business Overview
Table 167. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Product
Table 169. Yangtze River Pharmaceutical Recent Development
Table 170. Qianjiang Pharmaceuticals Corporation Information
Table 171. Qianjiang Pharmaceuticals Description and Business Overview
Table 172. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Product
Table 174. Qianjiang Pharmaceuticals Recent Development
Table 175. Wuhan Hualong Corporation Information
Table 176. Wuhan Hualong Description and Business Overview
Table 177. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Product
Table 179. Wuhan Hualong Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Human Herpersvirus 5 (HHV-5) Drug Distributors List
Table 183. Human Herpersvirus 5 (HHV-5) Drug Customers List
Table 184. Human Herpersvirus 5 (HHV-5) Drug Market Trends
Table 185. Human Herpersvirus 5 (HHV-5) Drug Market Drivers
Table 186. Human Herpersvirus 5 (HHV-5) Drug Market Challenges
Table 187. Human Herpersvirus 5 (HHV-5) Drug Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Herpersvirus 5 (HHV-5) Drug Product Picture
Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Ganciclovir Product Picture
Figure 4. Valerian Gilivir Drugs Product Picture
Figure 5. Acyclovir Drugs Product Picture
Figure 6. Valacyclovir Drugs Product Picture
Figure 7. Foscarnet Sodium Drugs Product Picture
Figure 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Immunodeficiency Crowd Examples
Figure 10. Organ Transplant Crowd Examples
Figure 11. CMV Herpes Crowd Examples
Figure 12. Global Human Herpersvirus 5 (HHV-5) Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Herpersvirus 5 (HHV-5) Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) Growth Rate (2016-2027)
Figure 15. Global Human Herpersvirus 5 (HHV-5) Drug Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Human Herpersvirus 5 (HHV-5) Drug Sales (K Units) Growth Rate (2016-2027)
Figure 20. Europe Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Human Herpersvirus 5 (HHV-5) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Human Herpersvirus 5 (HHV-5) Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Human Herpersvirus 5 (HHV-5) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Human Herpersvirus 5 (HHV-5) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Human Herpersvirus 5 (HHV-5) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Human Herpersvirus 5 (HHV-5) Drug Players Market Share by Revenue in Human Herpersvirus 5 (HHV-5) Drug: 2016 & 2020
Figure 31. Human Herpersvirus 5 (HHV-5) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Type (2016-2021)
Figure 33. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Application (2016-2021)
Figure 35. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 37. North America Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 38. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 39. Europe Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 40. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 41. China Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 42. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 43. Japan Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 46. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Type in 2020
Figure 47. India Human Herpersvirus 5 (HHV-5) Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Human Herpersvirus 5 (HHV-5) Drug
Figure 50. Manufacturing Process Analysis of Human Herpersvirus 5 (HHV-5) Drug
Figure 51. Human Herpersvirus 5 (HHV-5) Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed